Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
ChemPhysMater 1:294309
For most individuals, particularly beginners, topical application is the recommended and safest starting point, offering localized benefits with a strong safety record
Both Retatrutide and GHK-Cu use this route
Physician-guided IV therapy for recovery, energy, immunity, beauty, and performance
Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing
Clin Cancer Res 15(4):1326-1334, 2009
US$ 28.72
US$ 28.85
US$ 20.35
